Concepedia

Julie Gay

JG

Statistics

Publications

13

Citations

1K

H-Index

11

Active since

1997

Affiliations

Assistance Publique – Hôpitaux de Paris(Current)

Sorbonne Université

Centre Hospitalier de la Côte Basque

Centre Hospitalier Universitaire de Rennes

Institut Paoli-Calmettes

Julie Gay is an author at Assistance Publique – Hôpitaux de Paris specializing in medicine, hematologic malignancy therapy, and hematology.

Publications per year

1997–2025

13

Publications

13

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Preemptive rituximab infusions after remission efficiently prevent relapses in acquired thrombotic thrombocytopenic purpura

Julie Gay, Lionel Galicier, François Provôt et al. · Blood · 2014 · 188 citations · Full text

Medicine, Hematology, Immunology +6

Early Human Herpesvirus Type 6 Reactivation after Allogeneic Stem Cell Transplantation: A Large-Scale Clinical Study

Rémy Duléry, Julia Salleron, A. Dewilde et al. · Biology of Blood and Marrow Transplantation · 2011 · 115 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Isatuximab, lenalidomide, dexamethasone and bortezomib in transplant-ineligible multiple myeloma: the randomized phase 3 BENEFIT trial

Xavier Leleu, Cyrille Hulin, Jérôme Lambert et al. · Nature Medicine · 2024 · 107 citations · Full text

Medicine, Hematology, Pharmacotherapy +17

Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma

Aurore Perrot, Jérôme Lambert, Cyrille Hulin et al. · New England Journal of Medicine · 2025 · 56 citations

Medicine, Oncology, Cell Therapy +14

1–5 of 13